AssetMark’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
AssetMark's NVAX Position: Q3 2026 in Review
AssetMark held its Novavax (NVAX) position steady in Q3 2026 at 241 shares worth $2.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2969.
AssetMark first reported a position in NVAX in Q4 2015 and has held it in 6 quarters since. 195 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.
- AssetMark held 241 shares of Novavax worth $2.6K as of Q3 2026.
- AssetMark left its Novavax share count unchanged in Q3 2026.
- Novavax made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #2969 holding.
- AssetMark first reported a position in Novavax in Q4 2015 and has held it in 6 quarters since.
- 195 funds tracked by Wall St. Rank held Novavax as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.